Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

An ad-supported tier allows for more users to join who would otherwise feel the service is too expensive and the numbers back ...

Philippe Laffont's hedge fund, Coatue Management, just made a major purchase in a non-traditional data center stock.

Remitly (RELY) stock has underperformed the market this year, falling by over 22% even as the Nasdaq 100 and S&P 500 indices ...

We recently compiled a list of the 10 Best US Stocks to Buy Under $10. In this article, we are going to take a look at where ...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Alphabet fair value estimate is US$242 Current share price ...

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 17th: Nexxen ...

Rani Therapeutics (NASDAQ:RANI – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a note issued to investors on Friday, MarketBeat Ratings reports.

The outlook for Entegris has become more uncertain for various reasons. Find out why I maintain my hold rating on ENTG stock.

S&P 500 is historically expensive, with high PE and price-to-sales ratios, suggesting lower future returns for index fund ...

EVP Scott Belsky sold 1,530 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an ...

The growth characteristics of Take-Two are excellent, and GTA VI could be a big blockbuster. Read why I'm neutral on TTWO ...